title: Combination of EGFR and COX-2 inhibitors in breast cancer patient.
abstract: Ther combination of EGFR and COX-2 inhibitors in breast cancer patient treatment is a topic of interest. In this work, the author discusses on the synergistic effect of concomitant usage of the two drugs and also further notes on the myth in using this combination.
authors.affiliation: Wiwanitkit House, Bangkhae, Bangkok, Thailand. wviroj@yahoo.com
authors.forename: Viroj
authors.initials: V
authors.lastname: Wiwanitkit
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D000068579:Celecoxib; D059447:Cell Cycle Checkpoints / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D005260:Female; D006801:Humans; D011720:Pyrazoles / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D011720:Pyrazoles; D013449:Sulfonamides; C501466:nimotuzumab; D000068579:Celecoxib